Cancer drug can treat drug-resistant herpes, too

UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. Their work appears in the journal Drug Resistance Updates.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup